Baroda BNP Paribas Health and Wellness Fund

The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.

Growthvine rating: 1/5 — ranked #86 of 87 in category.

Fund basics

CategoryEquity: Sectoral
NAV₹11.05 (as of 2026-11-13)
AUM₹487 Cr
Expense ratio2.09%
RiskometerVery High
Fund managerAnkeet Pandya
Exit loadFor units in excess of 10% of the investment, 1% will be charged for redemption within 1 year

Performance & risk

Standard deviation0.00%
Max drawdown−11.93%
Alpha0
Beta0

Over 5 years, captured 74.1% of NIFTY Pharma's upside and 124.7% of its downside.

Market cap allocation

Large cap33.1%
Mid cap46.3%
Small cap20.6%

Concentration

Top 5 holdings38.3%
Top 10 holdings59.9%
Total holdings33

Top holdings

Top sectors

Calendar-year track record

YearReturnQuartileCategory rank
2026 (partial)16.9%Q1 (Top)#14 of 76